Daxor Corporation, the global leader in blood volume measurement technology, today announces new data validating the benefits of the Company’s BVA-100 diagnostic blood test in reducing hospital length of stay (LOS) for heart failure (HF) patients. Data were presented at the Heart Failure Society of America (HFSA) Annual Scientific Meeting (ASM) 2022 – which brought… Read More
The study was done in collaboration with renowned virologist, Dr. Colleen B. Jonsson, Harriet Van Vleet Professor of Virology, Director of the Regional Biocontainment Laboratory (RBL), and Director of the Institute for the Study of Host-Pathogen Systems at the University of Tennessee Health Sciences Center (UTHSC), who remarked: “We tested RHB-107 and opaganib using a primary human nasal epithelial cell… Read More
Aquestive Therapeutics, Inc. (NASDAQ: AQST), a pharmaceutical company advancing medicines to solve patients’ problems with current standards of care and provide transformative products to improve their lives, announced today the establishment of a Scientific Advisory Board comprised of eight allergy experts. Jay Lieberman, MD, is currently an Associate Professor at the University of Tennessee Health Science… Read More
Provectus (OTCQB: PVCT) today announced that the Company has expanded its sponsored research program with Michio Kurosu, PhD, Professor, Department of Pharmaceutical Sciences at the College of Pharmacy of the University of Tennessee Health Science Center (UTHSC) in Memphis, Tennessee to investigate Provectus’ pharmaceutical-grade rose bengal for the treatment of anti-fungal and anti-oral bacterial infections.… Read More
The NCPDP Foundation Board of Trustees, who govern the 501(c)(3) nonprofit charitable organization that is affiliated with NCPDP, has awarded a $100,000 grant to University of Tennessee Health Science Center (UTHSC) College of Pharmacy for a research project to demonstrate the clinical value of integrating the NCPDP/HL7 Pharmacist eCare Plan (PeCP) in pharmacy and medical… Read More
